Tetsuya Nakatsura was born in Kagoshima, Japan, in 1967. He has been a Section Head of the Section for Cancer Immunotherapy at the Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba Prefecture, Japan, since October 2005. He was graduated from the Kumamoto University School of Medicine in 1992. He was trained as a Surgeon at the Department of Surgery II and at the National Cancer Center Hospital East, for 5.5 years. Nakatsura has joined the Department of Immunogenetics where he directed basic cancer research at the Kumamoto University Graduate School of Medical Sciences from 1997 to 2001. He graduated with a Ph.D. degree from the Kumamoto University Graduate School of Medical Sciences, in 2001. He has worked as an Assistant Professor at the same department for the next 4 years. In October 2005, he was promoted to the present position and has begun to study the phase I trial of GPC3-derived peptide vaccine for advanced HCC patients at the National Cancer Center Hospital East. Nakatsura received the Incitement Award of the Japanese Cancer Association (2006) and The Second Japan Research Foundation for Clinical Pharmacology Research Award (2009). The Cancer Immunotherapy Project aims to investigate evidence-based cancer immunotherapy, repeating basic research and translational research. This project is focused on developing not only more effective immunotherapies but also immunological method for suppression of recurrence or for cancer prevention.
Biography Updated on 4 October 2011